ICU Medical Stockholder Meeting Results Announced
Ticker: ICUI · Form: 8-K · Filed: May 16, 2024 · CIK: 883984
| Field | Detail |
|---|---|
| Company | Icu Medical Inc/De (ICUI) |
| Form Type | 8-K |
| Filed Date | May 16, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, annual-meeting, stockholder-vote
Related Tickers: ICUI
TL;DR
ICU Medical shareholders voted on directors, auditor, and executive pay at their May 15th meeting.
AI Summary
On May 15, 2024, ICU Medical, Inc. filed an 8-K report to announce the results of its annual meeting of stockholders held on May 15, 2024. The company provided details on the election of directors, the ratification of its independent registered public accounting firm, and advisory votes on executive compensation.
Why It Matters
This filing provides transparency on key corporate governance decisions made by ICU Medical's shareholders, including the composition of its board and executive compensation.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of annual meeting results and does not present new financial or operational risks.
Key Players & Entities
- ICU MEDICAL, INC. (company) — Registrant
- May 15, 2024 (date) — Date of annual meeting and report
- Delaware (jurisdiction) — State of incorporation
- 951 Calle Amanecer, San Clemente, California 92673 (address) — Principal executive offices
FAQ
What was the primary purpose of the May 15, 2024 8-K filing for ICU Medical, Inc.?
The primary purpose was to report the results of the company's annual meeting of stockholders held on May 15, 2024.
Who were the key items voted on by ICU Medical's security holders at the annual meeting?
The key items voted on included the election of directors, the ratification of the appointment of the independent registered public accounting firm, and an advisory vote on the compensation of the company's named executive officers.
When was the annual meeting of stockholders held?
The annual meeting of stockholders was held on May 15, 2024.
What is ICU Medical, Inc.'s state of incorporation?
ICU Medical, Inc. is incorporated in Delaware.
What is the address of ICU Medical, Inc.'s principal executive offices?
The address of ICU Medical, Inc.'s principal executive offices is 951 Calle Amanecer, San Clemente, California 92673.
Filing Stats: 588 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-05-16 14:55:18
Key Financial Figures
- $0.10 — ich registered Common stock, par value $0.10 per share ICUI The Nasdaq Stock Market
Filing Documents
- icui-20240515.htm (8-K) — 47KB
- 0000883984-24-000018.txt ( ) — 168KB
- icui-20240515.xsd (EX-101.SCH) — 2KB
- icui-20240515_lab.xml (EX-101.LAB) — 21KB
- icui-20240515_pre.xml (EX-101.PRE) — 12KB
- icui-20240515_htm.xml (XML) — 3KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. At the 2024 Annual Meeting of stockholders of ICU Medical, Inc. (the "Company") held on May 15, 2024, the following proposals were voted on by the Company's stockholders, and the results were as set forth below: Proposal 1. Election of directors. Name of Nominee Votes For Withheld Broker Non-Votes Vivek Jain 20,942,296 570,606 1,202,538 David C. Greenberg 21,240,431 272,471 1,202,538 Elisha W. Finney 20,884,785 628,117 1,202,538 David F. Hoffmeister 20,171,624 1,341,278 1,202,538 Donald M. Abbey 21,235,342 277,560 1,202,538 Laurie Hernandez 21,272,637 240,265 1,202,538 Kolleen T. Kennedy 21,268,112 244,790 1,202,538 The Company's stockholders elected each of the director nominees to serve as a director until the next annual meeting of stockholders or until their respective successor is elected and qualified. Proposal 2. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes For Votes Against Votes Abstained 22,484,283 222,466 8,691 The Company's stockholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. Proposal 3. Approve the advisory vote on the Company's named executive officer compensation. Votes For Votes Against Votes Abstained Broker Non-Votes 20,673,543 824,221 15,138 1,202,538 The Company's stockholders approved, on an advisory basis, the Company's named executive officer compensation. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ICU MEDICAL, INC. Date: May 16, 2024 By: /s/ Brian M. Bonnell Brian M. Bonnell Chief Financial Officer